vs
Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and Third Coast Bancshares, Inc. (TCBX). Click either name above to swap in a different company.
Third Coast Bancshares, Inc. is the larger business by last-quarter revenue ($57.7M vs $47.7M, roughly 1.2× IRONWOOD PHARMACEUTICALS INC). Third Coast Bancshares, Inc. runs the higher net margin — 28.4% vs -4.8%, a 33.1% gap on every dollar of revenue. Over the past eight quarters, Third Coast Bancshares, Inc.'s revenue compounded faster (17.5% CAGR vs -20.2%).
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
Third Coast Bancshares, Inc. is a regional financial holding company headquartered in the U.S. Gulf Coast region. It provides a full suite of commercial and retail banking services including deposit products, business and consumer loans, mortgage services, and wealth management solutions, serving local small and medium-sized enterprises, individual consumers, and community clients across Texas and surrounding areas.
IRWD vs TCBX — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $47.7M | $57.7M |
| Net Profit | $-2.3M | $16.4M |
| Gross Margin | — | — |
| Operating Margin | 14.3% | — |
| Net Margin | -4.8% | 28.4% |
| Revenue YoY | -47.3% | — |
| Net Profit YoY | -200.9% | 20.5% |
| EPS (diluted) | $0.01 | $0.88 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $57.7M | ||
| Q4 25 | $47.7M | $56.5M | ||
| Q3 25 | $122.1M | $54.5M | ||
| Q2 25 | $85.2M | $52.0M | ||
| Q1 25 | $41.1M | $45.9M | ||
| Q4 24 | $90.5M | $46.3M | ||
| Q3 24 | $91.6M | $42.9M | ||
| Q2 24 | $94.4M | $41.7M |
| Q1 26 | — | $16.4M | ||
| Q4 25 | $-2.3M | $17.9M | ||
| Q3 25 | $40.1M | $18.1M | ||
| Q2 25 | $23.6M | $16.7M | ||
| Q1 25 | $-37.4M | $13.6M | ||
| Q4 24 | $2.3M | $13.7M | ||
| Q3 24 | $3.6M | $12.8M | ||
| Q2 24 | $-860.0K | $10.8M |
| Q1 26 | — | — | ||
| Q4 25 | 14.3% | 38.1% | ||
| Q3 25 | 61.8% | 41.9% | ||
| Q2 25 | 53.2% | 40.5% | ||
| Q1 25 | -70.7% | 37.8% | ||
| Q4 24 | 34.8% | 38.7% | ||
| Q3 24 | 28.0% | 37.9% | ||
| Q2 24 | 26.5% | 34.1% |
| Q1 26 | — | 28.4% | ||
| Q4 25 | -4.8% | 31.7% | ||
| Q3 25 | 32.8% | 33.1% | ||
| Q2 25 | 27.7% | 32.2% | ||
| Q1 25 | -90.9% | 29.6% | ||
| Q4 24 | 2.5% | 29.7% | ||
| Q3 24 | 4.0% | 29.8% | ||
| Q2 24 | -0.9% | 25.9% |
| Q1 26 | — | $0.88 | ||
| Q4 25 | $0.01 | $1.02 | ||
| Q3 25 | $0.23 | $1.03 | ||
| Q2 25 | $0.14 | $0.96 | ||
| Q1 25 | $-0.23 | $0.78 | ||
| Q4 24 | $0.03 | $0.80 | ||
| Q3 24 | $0.02 | $0.74 | ||
| Q2 24 | $-0.01 | $0.63 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.5M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-261.8M | $650.5M |
| Total Assets | $396.9M | $6.6B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $215.5M | $175.2M | ||
| Q3 25 | $140.4M | $116.4M | ||
| Q2 25 | $92.9M | $113.1M | ||
| Q1 25 | $108.5M | $219.0M | ||
| Q4 24 | $88.6M | $371.2M | ||
| Q3 24 | $88.2M | $258.2M | ||
| Q2 24 | $105.5M | $241.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $199.5M | — | ||
| Q2 25 | $199.3M | — | ||
| Q1 25 | $199.2M | — | ||
| Q4 24 | $199.0M | — | ||
| Q3 24 | $198.8M | — | ||
| Q2 24 | $198.6M | — |
| Q1 26 | — | $650.5M | ||
| Q4 25 | $-261.8M | $531.0M | ||
| Q3 25 | $-264.2M | $513.8M | ||
| Q2 25 | $-308.2M | $496.1M | ||
| Q1 25 | $-334.1M | $479.8M | ||
| Q4 24 | $-301.3M | $460.7M | ||
| Q3 24 | $-311.3M | $450.5M | ||
| Q2 24 | $-321.7M | $435.0M |
| Q1 26 | — | $6.6B | ||
| Q4 25 | $396.9M | $5.3B | ||
| Q3 25 | $396.1M | $5.1B | ||
| Q2 25 | $342.9M | $4.9B | ||
| Q1 25 | $327.2M | $4.9B | ||
| Q4 24 | $350.9M | $4.9B | ||
| Q3 24 | $389.5M | $4.6B | ||
| Q2 24 | $395.6M | $4.5B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $74.6M | — |
| Free Cash FlowOCF − Capex | $74.6M | — |
| FCF MarginFCF / Revenue | 156.3% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $127.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $74.6M | $50.8M | ||
| Q3 25 | $47.6M | $20.7M | ||
| Q2 25 | $-15.1M | $13.9M | ||
| Q1 25 | $20.0M | $10.5M | ||
| Q4 24 | $15.2M | $35.1M | ||
| Q3 24 | $9.9M | $22.0M | ||
| Q2 24 | $33.5M | $7.3M |
| Q1 26 | — | — | ||
| Q4 25 | $74.6M | — | ||
| Q3 25 | $47.6M | — | ||
| Q2 25 | $-15.1M | — | ||
| Q1 25 | $19.9M | — | ||
| Q4 24 | — | $33.4M | ||
| Q3 24 | $9.9M | — | ||
| Q2 24 | $33.4M | — |
| Q1 26 | — | — | ||
| Q4 25 | 156.3% | — | ||
| Q3 25 | 39.0% | — | ||
| Q2 25 | -17.7% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | 72.1% | ||
| Q3 24 | 10.8% | — | ||
| Q2 24 | 35.4% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.0% | 3.8% | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.1% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 2.84× | ||
| Q3 25 | 1.19× | 1.15× | ||
| Q2 25 | -0.64× | 0.83× | ||
| Q1 25 | — | 0.77× | ||
| Q4 24 | 6.74× | 2.56× | ||
| Q3 24 | 2.71× | 1.72× | ||
| Q2 24 | — | 0.68× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRWD
Segment breakdown not available.
TCBX
| Net Interest Income | $53.6M | 93% |
| Noninterest Income | $4.0M | 7% |
